» Articles » PMID: 37547981

BACE2 Deficiency Impairs Expression and Function of Endothelial Nitric Oxide Synthase in Brain Endothelial Cells

Overview
Journal J Neurochem
Specialties Chemistry
Neurology
Date 2023 Aug 7
PMID 37547981
Authors
Affiliations
Soon will be listed here.
Abstract

Beta-site amyloid precursor protein (APP)-cleaving enzyme 2 (BACE2) is highly expressed in cerebrovascular endothelium. Notably, BACE2 is one of the most downregulated genes in cerebrovascular endothelium derived from patients with Alzheimer's disease. The present study was designed to determine the role of BACE2 in control of expression and function of endothelial nitric oxide synthase (eNOS). Genetic downregulation of BACE2 with small interfering RNA (BACE2siRNA) in human brain microvascular endothelial cells (BMECs) significantly decreased expression of eNOS and elevated levels of eNOS phosphorylated at threonine residue Thr495, thus leading to reduced production of nitric oxide (NO). BACE2siRNA also suppressed expression of APP and decreased production and release of soluble APPα (sAPPα). In contrast, adenovirus-mediated overexpression of APP increased expression of eNOS. Consistent with these observations, nanomolar concentrations of sAPPα and APP 17mer peptide (derived from sAPPα) augmented eNOS expression. Further analysis established that γ-aminobutyric acid type B receptor subunit 1 and Krüppel-like factor 2 may function as downstream molecular targets significantly contributing to BACE2/APP/sAPPα-induced up-regulation of eNOS. In agreement with studies on cultured human endothelium, endothelium-dependent relaxations to acetylcholine and basal production of cyclic GMP were impaired in cerebral arteries of BACE2-deficient mice. We propose that in the brain blood vessels, BACE2 may function as a vascular protective protein.

Citing Articles

Secretase promotes AD progression: simultaneously cleave Notch and APP.

Yang K, Zhang J, Feng M, Yao K, Liu Y, Zhou M Front Aging Neurosci. 2024; 16:1445470.

PMID: 39634655 PMC: 11615878. DOI: 10.3389/fnagi.2024.1445470.


Cerebrovascular Endothelial Dysfunction: Role of BACE1.

Katusic Z, Duscio L, He T Arterioscler Thromb Vasc Biol. 2024; 44(8):1737-1747.

PMID: 38868939 PMC: 11269044. DOI: 10.1161/ATVBAHA.124.320798.

References
1.
Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher A . Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature. 1999; 399(6736):601-5. DOI: 10.1038/21224. View

2.
Chen X, Chen L, Lin G, Wang Z, Kodali M, Li M . White matter damage as a consequence of vascular dysfunction in a spontaneous mouse model of chronic mild chronic hypoperfusion with eNOS deficiency. Mol Psychiatry. 2022; 27(11):4754-4769. PMC: 9734049. DOI: 10.1038/s41380-022-01701-9. View

3.
Brandes R, Kim D, Schmitz-Winnenthal F, Amidi M, Godecke A, Mulsch A . Increased nitrovasodilator sensitivity in endothelial nitric oxide synthase knockout mice: role of soluble guanylyl cyclase. Hypertension. 2000; 35(1 Pt 2):231-6. DOI: 10.1161/01.hyp.35.1.231. View

4.
Austin S, Katusic Z . Partial loss of endothelial nitric oxide leads to increased cerebrovascular beta amyloid. J Cereb Blood Flow Metab. 2019; 40(2):392-403. PMC: 7370614. DOI: 10.1177/0271678X18822474. View

5.
Forstermann U, Sessa W . Nitric oxide synthases: regulation and function. Eur Heart J. 2011; 33(7):829-37, 837a-837d. PMC: 3345541. DOI: 10.1093/eurheartj/ehr304. View